MedPath

The Effect of Royal Jelly on the recovery of Hepatitis B patients

Phase 1
Recruiting
Conditions
Hepatitis B.
Acute hepatitis B
Registration Number
IRCT20210329050786N1
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Infected with Hepatitis B for more than six months

Exclusion Criteria

Infected by other viruses
Suffering from immune related diseases
Receiving drugs that affect the immune system

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gene expression of Toll-like receptors will be measured in the Hepatitis B infected patients before and after oral administration of Royal Jelly. Timepoint: Before and after taking Royal Jelly orally. Method of measurement: Real time PCR assay.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath